Physician profile
Mark D Pinzel
NPI 1386786051
$805.96
in general payments reported to CMS, 2019-2025
16 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.81 · 2022: $131 · 2023: $109 · 2024: $231 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $142.87 | 2022-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Pfizer INC. | $112.03 | 2023-2025 | |
| Sanofi Pasteur INC. | $89.37 | 2024-2025 | |
| Corium, LLC | $88.25 | 2022-2024 | Azstarys |
| Glaxosmithkline, LLC. | $62.10 | 2022-2025 | Bexsero, Penmenvy |
| Seqirus USA INC | $53.03 | 2022-2025 | Flucelvax |
| Cranial Technologies, INC | $48.23 | 2025 | Doc Band |
| Exeltis, USA INC. | $35.64 | 2022-2024 | Slynd |
| Supernus Pharmaceuticals, INC. | $32.98 | 2025 | Qelbree |
| Ars Pharmaceuticals Operations, INC. | $30.73 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $23.23 | 2024 | Aptima |
| Alk-Abello, INC | $22.22 | 2025 | Neffy |
| Viiv Healthcare Company | $18.81 | 2021 | |
| Biomarin Pharmaceutical INC. | $16.01 | 2024 | |
| Kaleo, INC. | $15.41 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pinzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.